Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.
about
Intraoperative floppy iris syndrome: pathophysiology, prevention, and treatmentFinasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.Chemoprevention of prostate cancer.Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor SyndromeUse of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineFactor analysis of the modified Sexual Adjustment Questionnaire-MaleHealth-related quality-of-life findings for the prostate cancer prevention trialNon-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial.Finasteride in the treatment of patients with benign prostatic hyperplasia: a reviewEnhancing nurse contributions to SWOG clinical trials.Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride.Prostate cancer prevention: concepts and clinical recommendations.Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.Finasteride-its impact on sexual function and prostate cancer.Finasteride and sexual side effects.Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract.Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia.Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride.
P2860
Q33623451-9F5B32E4-D5D9-4E28-A1D7-269D506B0797Q33710942-6005FE3B-2FC4-4B72-A4D0-02F8BEFBBD6CQ33750580-83BBA455-670A-496D-8701-74322ED22FFCQ34186757-B372B25B-0E5F-4AE0-89C0-B77D90629E54Q34457965-191B5E25-5458-4BF0-B0E4-4A7E5DA69B3EQ34552026-DBD83DA6-1E21-4094-9B66-DE506A4642F3Q34604979-EEE3B77A-2C87-4CFC-88D2-01A862245A91Q36330986-CE2CD149-9AE5-45A0-B08E-E7EABDBADEE9Q36486786-78BBCFF7-2CC0-4CC4-9047-1EE10ABB77BCQ36781932-985FF278-0D10-4170-8FF4-10D645C6E32CQ37261063-B6E3ACD9-0E81-4D72-ADD9-D3AEE4E41750Q37651986-13E63C93-7EF4-493E-8AE7-33D8AB0833C8Q37694089-5AA52DB6-60A0-475A-A177-DDC52EFF8131Q37766754-306642B5-5672-4617-8C5C-93B5757351C7Q38814349-B206C735-8BC6-49A9-A589-E761D7A2F62AQ39168087-E7EAA991-BBE3-441D-A713-9E2A74D8F887Q39681594-5DF10613-A834-498E-A030-47195B92E59FQ42134250-D43B08E6-E70D-4263-9730-F6134F098109Q48183066-6D8C2DB6-4384-47EE-9950-AA96A2A8945CQ49039304-62BB49E7-FB63-4F89-96E2-C4136A9D419DQ55354556-9FDEC4D6-4440-4A20-954A-95070E72F8F9
P2860
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Longitudinal analysis of sexua ...... state Cancer Prevention Trial.
@en
Longitudinal analysis of sexua ...... state Cancer Prevention Trial.
@nl
type
label
Longitudinal analysis of sexua ...... state Cancer Prevention Trial.
@en
Longitudinal analysis of sexua ...... state Cancer Prevention Trial.
@nl
prefLabel
Longitudinal analysis of sexua ...... state Cancer Prevention Trial.
@en
Longitudinal analysis of sexua ...... state Cancer Prevention Trial.
@nl
P2093
P356
P1476
Longitudinal analysis of sexua ...... state Cancer Prevention Trial.
@en
P2093
Carol M Moinpour
Charles A Coltman
Connie Langley
Donald L Patrick
Gary W Donaldson
Ian M Thompson
John E Ware
Patricia A Ganz
Sally A Shumaker
Scott M Lippman
P304
P356
10.1093/JNCI/DJM023
P407
P577
2007-06-27T00:00:00Z